Abstract:Long interspersed element 1 (LINE-1; L1) are a family of transposons that occupy ~17% of the human genome. Though a small number of L1 copies remain capable of autonomous transposition, the overwhelming majority of copies are degenerate and immobile. Nevertheless, both mobile and immobile L1s can exert pleiotropic effects (promoting genome instability, inflammation, or cellular senescence) on their hosts, and L1's contributions to aging and aging diseases is an area of active research. However, because of the cell type-specific nature of transposon control, the catalogue of L1 regulators remains incomplete. Here, we employ an eQTL approach leveraging transcriptomic and genomic data from the GEUVADIS and 1000Genomes projects to computationally identify new candidate regulators of L1 RNA levels in lymphoblastoid cell lines. To cement the role of candidate genes in L1 regulation, we experimentally modulate the levels of top candidates in vitro , including IL16 , STARD5 , HSD17B12 , and RNF5 , and assess changes in TE family expression by Gene Set Enrichment Analysis (GSEA). Remarkably, we observe subtle but widespread upregulation of TE family expression following IL16 and STARD5 overexpression. Moreover, a short-term 24-hour exposure to recombinant human IL16 was sufficient to transiently induce subtle, but widespread, upregulation of L1 subfamilies. Finally, we find that many L1 expression-associated genetic variants are co-associated with aging traits across genome-wide association study databases. Our results expand the catalogue of genes implicated in L1 RNA control and further suggest that L1-derived RNA contributes to aging processes. Given the ever-increasing availability of paired genomic and transcriptomic data, we anticipate this new approach to be a starting point for more comprehensive computational scans for regulators of transposon RNA levels. Transposable elements, or jumping genes, are fragments of DNA that have or once had the ability to mobilize to a new location within our genome. In humans, the most abundant transposable element is LINE-1 (L1), accounting for ~17% of our total DNA. Though L1 is generally repressed in healthy human cells, depression of transposable elements (including L1) has been observed in aging and in aging-associated diseases. Additionally, there is increasing evidence that L1 transcriptional levels may promote features of aging, highlighting the importance of understanding the mechanisms that regulate L1 RNA levels. Here, we computationally identify new candidate regulators of L1 RNA levels, provide experimental evidence that candidate regulators influence L1 RNA levels, and demonstrate that genetic variants associated with differences in L1 RNA levels are co-associated with aging phenotypes. Our approach expands the toolkit that can be used to characterize transposable element regulation and highlights specific genes for further study. Importantly, our results reiterate the notion that L1 levels are linked with aging phenotypes and represent a potential therapeutic target for age-related decline.

The Transcription Factor PAX5 Activates Human LINE1 Retrotransposons to Induce Cellular Senescence

PAX5 Interacts with RIP2 to Promote NF-κB Activation and Drug-Resistance of B-lymphoproliferative Disorders

The Sirtuin-Associated Human Senescence Program Converges on the Activation of Placenta-Specific Gene PAPPA

An eQTL-based approach reveals candidate regulators of LINE-1 RNA levels in lymphoblastoid cells

LINE-1 RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes

FOXA1 Mediates P16ink4a Activation During Cellular Senescence

LINE-1 Transposable Element Renaissance in Aging and Age-Related Diseases

Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation

RSL1D1 modulates cell senescence and proliferation via regulation of PPARγ mRNA stability

PPARγ Accelerates Cellular Senescence by Inducing P16ink4α Expression in Human Diploid Fibroblasts

Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability

FOXA1 mediates p16(INK4a) activation during cellular senescence.

AP-1 imprints a reversible transcriptional programme of senescent cells

Cathepsin L induces cellular senescence by upregulating CUX1 and p16INK4a

Downregulation of Splicing Factor PTBP1 Curtails FBXO5 Expression to Promote Cellular Senescence in Lung Adenocarcinoma

cGAS deficient mice display premature aging associated with de-repression of LINE1 elements and inflammation

Integrated multi-omics approach revealed cellular senescence landscape

Spurious intragenic transcription is a feature of mammalian cellular senescence and tissue aging

SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer